Dr Gary Michael Weiss, MD | |
167 Kualapa Pl, Lahaina, HI 96761-2902 | |
(952) 595-1100 | |
(952) 942-3361 |
Full Name | Dr Gary Michael Weiss |
---|---|
Gender | Male |
Speciality | Radiology - Diagnostic Radiology |
Location | 167 Kualapa Pl, Lahaina, Hawaii |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1235114505 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | ME37447 (Florida) | Secondary |
2085R0202X | Radiology - Diagnostic Radiology | MD9383 (Hawaii) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Gary Michael Weiss, MD 11995 Singletree Ln, Suite 500, Eden Prairie, MN 55344-5347 Ph: (952) 595-1100 | Dr Gary Michael Weiss, MD 167 Kualapa Pl, Lahaina, HI 96761-2902 Ph: (952) 595-1100 |
News Archive
By combining a magnetic nanoparticle, a fluorescent quantum dot, and an anticancer drug within a lipid-based nanoparticle, a multi-institutional research team headed by members of the National Cancer Institute's (NCI) Alliance for Nanotechnology in Cancer has created a single agent that can image and treat tumors. In addition, this new nanoparticle is able to avoid detection by the immune system, enabling the particle to remain in the body for extended periods of time.
How did the simple act of eating become so difficult? Between basic nutrition, the obesity epidemic, allergies, food recalls, and chemical contaminants, feeding children a healthy diet has never been so complicated. Eat Healthy, a new program from Healthy Child Healthy World, makes it easy.
Researchers from Sechenov University together with Russian and Iranian colleagues described currently known approaches to the treatment of SARS-CoV-2 infection.
The rate of non-Hispanic white youth diagnosed with type 1 diabetes increased significantly from 2002 to 2009 in all but the youngest age group of children, according to a new study published today in the journal Diabetes.
TGen Drug Development (TD2) and Oncoholdings Inc. announced today a partnership agreement that could lead to the prompt development of new anti-cancer agents.
› Verified 1 days ago